Blood Res 2013; 48(3):
Published online September 25, 2013
https://doi.org/10.5045/br.2013.48.3.222
© The Korean Society of Hematology
Department of Laboratory Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Correspondence to : Correspondence to Sang Gyung Kim, M.D. Department of Laboratory Medicine, Daegu Catholic University School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea. Phone: +82-53-650-4145, Fax: +82-53-653-8672, sgkim@cu.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Myelodysplastic syndrome (MDS) with eosinophilia is a rare condition and has yet to be classified under the 2008 World Health Organization classification. However, reports have described the prognostic significance of chronic persistent eosinophilia in MDS. Here, we report a case of a 67-year-old woman who was admitted to the hospital in July 2007 with generalized weakness, dizziness, and dyspnea on exertion persisting for 5 years. In the initial investigation, eosinophilia (22.1%) in peripheral blood and an increased proportion of eosinophils (5.6%) in normocellular bone marrow with dysplastic megakaryocytes and erythroid cells were noted. Eosinophilia was continuously detected during follow-up over 3 years. In a second bone marrow examination in August 2010, hypercellular bone marrow with similar features was observed. These findings led to the diagnosis of MDS with chronic persistent eosinophilia. To increase awareness of the prognostic significance of MDS with chronic eosinophilia, here we report a slow-progressing case of MDS with chronic persistent eosinophilia lasting over 6 years.
Keywords Myelodysplastic syndrome, Eosinophilia, Prognosis
Blood Res 2013; 48(3): 222-225
Published online September 25, 2013 https://doi.org/10.5045/br.2013.48.3.222
Copyright © The Korean Society of Hematology.
Min Ji Kim, Sung Hwa Bae, A Jin Lee, and Sang Gyung Kim*
Department of Laboratory Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Correspondence to: Correspondence to Sang Gyung Kim, M.D. Department of Laboratory Medicine, Daegu Catholic University School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea. Phone: +82-53-650-4145, Fax: +82-53-653-8672, sgkim@cu.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Myelodysplastic syndrome (MDS) with eosinophilia is a rare condition and has yet to be classified under the 2008 World Health Organization classification. However, reports have described the prognostic significance of chronic persistent eosinophilia in MDS. Here, we report a case of a 67-year-old woman who was admitted to the hospital in July 2007 with generalized weakness, dizziness, and dyspnea on exertion persisting for 5 years. In the initial investigation, eosinophilia (22.1%) in peripheral blood and an increased proportion of eosinophils (5.6%) in normocellular bone marrow with dysplastic megakaryocytes and erythroid cells were noted. Eosinophilia was continuously detected during follow-up over 3 years. In a second bone marrow examination in August 2010, hypercellular bone marrow with similar features was observed. These findings led to the diagnosis of MDS with chronic persistent eosinophilia. To increase awareness of the prognostic significance of MDS with chronic eosinophilia, here we report a slow-progressing case of MDS with chronic persistent eosinophilia lasting over 6 years.
Keywords: Myelodysplastic syndrome, Eosinophilia, Prognosis
Bone marrow (BM) aspirate smears showing dyserythropoiesis
High eosinophilia counts in peripheral blood were seen during the follow-up over 6 years (from July 2007 to June 2012).
Haeryung Lee, Nahee Ko, Sujin Namgoong, Seunghyok Ham and Jamin Koo
Blood Res 2024; 59():Young‑Uk Cho
Blood Res 2024; 59():Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai and Suporn Chuncharunee
Blood Res 2024; 59():
Bone marrow (BM) aspirate smears showing dyserythropoiesis
High eosinophilia counts in peripheral blood were seen during the follow-up over 6 years (from July 2007 to June 2012).